Walleye Capital
MDCO

Walleye Capital’s Medicines Co MDCO Stock Holding History

Walleye Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-90,809
Closed -$7.71M – 2051
2019
Q4 		$7.71M Buy
+90,809
New +$6.06M 0.5% 17

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Walleye Capital's MDCO Position: Q1 2020 in Review

Walleye Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 90,809 shares — an estimated $7.71M sold.

Walleye Capital first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $7.71M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Walleye Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Walleye Capital sold 90,809 Medicines Co shares in Q1 2020, an estimated $7.71M.
  • Walleye Capital first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Walleye Capital's Medicines Co position peaked at $7.71M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Walleye Capital's 13F filing for Q1 2020, filed 15 May 2020.